A- A A+

subLetter 5/2020

Neues Schulungsangebot von Hexal im Video-Blog-Format: Was gilt es beim Ausfüllen eines BtM-Rezeptes zu beachten? Wie lange behält ein BtM-Rezept seine Gültigkeit und wo muss dieses vor Verwendung aufbewahrt werden? Wie erfolgt die Vergabe von Substitutionsmitteln bei Sichtbezugspatienten und im Rahmen der Take-Home-Regelung? Welche Vorschriften gelten bei der Lieferung, Lagerung und Vernichtung von BtM?

Interview: „Ich habe nie Bedenken, eine Apotheke in die Substitutionsbehandlung einzubeziehen!“ 

Auf dem Land ist es für Substitutionspatienten schwierig, einen Substitutionsarzt in der Nähe des Wohnorts zu finden. Diese Erfahrung machte auch Dr. Werner Tauber. Als Oberarzt ist er am Standort Ansbach der Bezirkskliniken Mittelfranken u. a. für den stationären Drogenentzug und die ambulante Substitutionsgestützte Behandlung Opioidabhängiger zuständig. Um seine Patienten nach der Entlassung gut versorgt zu wissen, baute er ein Netzwerk aus 20 substituierenden Apotheken auf. 

Studie: Corona, „harte“ Szenen und Drogenhilfe – Zwischenergebnisse einer qualitativen Erhebung 

Studie: COVID-19 und der Freizeitdrogenkonsum


Australien. Impacts of COVID-19 and associated restrictions on people who use illicit stimulants in New South Wales: Findings from the Ecstasy and Related Drugs Reporting System 2020

The COVID-19 pandemic and restrictions on travel and gathering have likely had major impacts on drug supply, use and harms and there have been significant challenges with delivery of drug treatment and harm reduction services. People who use drugs may also be at increased risk of COVID-19 transmission because of the social nature of drug procurement and use. There have been urgent calls for evidence regarding the experiences of people who use drugs during the COVID-19 pandemic to inform public health efforts. Recognising the critical need for information, the Ecstasy and Related Drugs Reporting System (EDRS) project has been adapted to collect important data on people’s experiences during COVID-19. As such, this bulletin represents findings from 103 interviews undertaken in Sydney, NSW between 13 May and 23 June 2020, as part of the EDRS. (UNSW Sydney, National Drug and Alcohol Research Centre, September 2020)


UK. Prescription of alcohol in emergency homeless hotel accommodation during the COVID-19 lockdown

by Dr Emmert Roberts and Dr Emily Finch

During the COVID-19 lockdown in London, a number of people experiencing rough sleeping were temporarily housed in emergency hotel accommodation across the capital. As part of the city-wide substance misuse approach, individuals at risk of unplanned alcohol withdrawal were prescribed, provided with and purchased alcohol as a means of harm reduction. This allowed professionals to engage with individuals around their alcohol intake, provide education and advice on safe reduction regimens, and allowed time to build up relationships which we hope may have longer term impacts on individual drinking habits. (SSA – Society for the Study of Addiction, UK, 24.09.2020)


Kanada. Supporting people who use substances in shelter settings during the COVID‐19 pandemic - NATIONAL RAPID GUIDANCE 

Hyshka, K., Dong, K., Meador, K., Speed, K., Abele, B., LeBlanc, S., McFarlane, A., McNeil, R., Salokangas, E., Schoen, E., & Wild, T.C. 

Edmonton, Alberta: Canadian Research Initiative in Substance Misuse; May 17, 2020. 82 p. Version 1. 


New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol 

and Substance Use Disorders-The Perfect Storm. 

SPAGNOLO PA, Montemitro C, Leggio L.

Am J Psychiatry. 2020;177:805-807. 


A Pandemic within a Pandemic - Intimate Partner Violence during Covid-19. 

EVANS ML, Lindauer M, Farrell ME.

N Engl J Med. 2020 Sep 16. doi: 10.1056/NEJMp2024046. 


USA. ASAM releases major updates to COVID-19 guidance documents and resources regarding addiction treatment in the wake of COVID-19

As the leader in developing clinical guidelines and standards in addiction medicine, the American Society of Addiction Medicine takes our responsibility very seriously.  We convened the ASAM Caring for Patients During the COVID-19 (CPDC) Task Force to rapidly develop guidance tailored to addiction medicine treatment within the context of the COVID-19 pandemic. (American Society of Addiction Medicine, 18.09.2020)


WHO. The Access to COVID-19 Tools (ACT) Accelerator

The Access to COVID-19 Tools (ACT) Accelerator, is a groundbreaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines. (WHO, 2020)


USA. COVID-19 Science Update (CDC)

To help inform the COVID-19 response and help stay up to date on the latest COVID-19 research, CDC has created a series called COVID-19 Science Update. The first of its kind for a CDC emergency response, this series provides brief summaries of new COVID-19-related studies on many topics, including epidemiology, clinical treatment and management, laboratory science, and modeling. These summaries are released Tuesdays and Fridays and include an overview of key findings, methods, and implications. (CDC – Centers for Disease Control and Prevention, USA, 21.09.2020)


Deutsches Ärzteblatt online – Themenseite Impfen


Nonfatal Opioid Overdoses at an Urban Emergency Department During the COVID-19 Pandemic. 

Ochalek TA, Cumpston KL, Wills BK, Gal TS, Moeller FG. 

JAMA. Published online September 18, 2020. doi:10.1001/jama.2020.17477


Self-Reported Alcohol, Tobacco, and Cannabis Use during COVID-19 Lockdown Measures: Results from a Web-Based Survey. 

Vanderbruggen N, Matthys F, Van Laere S, Zeeuws D, Santermans L, Van den Ameele S, Crunelle C, L

Eur Addict Res 2020. doi: 10.1159/000510822


Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe

Han, Emeline et al.

The Lancet, Volume 0, Issue 0 


Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review. 

Nussbaumer-Streit  B, Mayr  V, Dobrescu  AI, Chapman  A, Persad  E, Klerings  I, Wagner  G, Siebert  U, Ledinger  D, Zachariah  C, Gartlehner  G. 

Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013574. DOI: 10.1002/14651858.CD013574.pub2.


Universal screening for SARS‐CoV‐2 infection: a rapid review. 

Viswanathan  M, Kahwati  L, Jahn  B, Giger  K, Dobrescu  AI, Hill  C, Klerings  I, Meixner  J, Persad  E, Teufer  B, Gartlehner  G. 

Cochrane Database of Systematic Reviews 2020, Issue 9. Art. No.: CD013718. DOI: 10.1002/14651858.CD013718.


Cochrane Special Collections: Coronavirus (COVID-19): Maßnahmen zur Infektionskontrolle und Prävention

Erstmals veröffentlicht am 4. März 2020 und fortlaufend aktualisiert; zuletzt aktualisiert am 02. September 2020 (Änderungen werden unten aufgeführt); alle Reviews in dieser Sonderkollektion sind frei zugänglich. (Cochrane Library, 22.09.2020)


USA. Nora's Blog: Addressing the Unique Challenges of COVID-19 for People in Recovery 

By Dr. Nora Volkow 

September is Recovery Month, an occasion to focus on the needs of the millions of people in the U.S. living with a substance use disorder (SUD) as well as celebrate those who are trying or succeeding in putting drug use behind them. The stress and isolation of the COVID-19 pandemic are presenting enormous challenges for these individuals, but ultimately the altered realities of healthcare may create opportunities to reach more people with services and possibly even increase the reach of recovery support systems. (NIDA – National Institute on Drug Abuse, USA, 14.09.2020)


The public health impact of Covid-19 beyond infection

In this article, Professor Maria Rosaria Galanti from Karolinska Institute provides her opinion on the adverse consequences of Covid-19. (European Society for Prevention Research - EUSPR Early Careers Forum, 23.09.2020)


Coronakrise: Viele Obdachlose auf psychiatrischen Akutstationen

Berlin – Soziale Isolation und Armut aufgrund der wirtschaftlichen Folgen der Coronapandemie können einen Einfluss auf die psychische Gesundheit haben, verbunden mit einem Anstieg von Depression und auch der Suizidraten.

Einen Einblick in die Folgen für die psychische Gesundheit, besonders sozial schwacher Menschen während der Pandemie, gab heute Andreas Heinz, Direktor der Klinik für Psychiatrie und Psychotherapie an der Charité – Universitätsmedizin Berlin, bei einem virtuellen Podiumsgespräch der Nationalen Akademie der Wissenschaften Leopoldina. (aerzteblatt.de, 28.09.2020)


Update: Characteristics of Health Care Personnel with COVID-19 — United States, February 12–July 16, 2020. 

Hughes MM, Groenewold MR, Lessem SE, et al. 

MMWR Morb Mortal Wkly Rep 2020;69:1364–1368. doi.org/10.15585/mmwr.mm6938a3


SARS-CoV-2 Infektion bei Mitarbeiterinnen und Mitarbeitern im Gesundheitswesen – Bedeutung der RT-PCR Testung 

AWMF-Register Nr. 040/015, Klasse : S1, Erstveröffentlichung 09/2020

Janssens, U. et al. 

Federführend; Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI), Berlin


Who gets a COVID vaccine first? Access plans are taking shape

Advisory groups around the world release guidance to prioritize health-care workers and those in front-line jobs. (Nature, 17.09.2020)


Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey

Zhou, Fuling et al.

EClinicalMedicine, Volume 0, Issue 0, 100510 


Understanding Mexican health worker COVID-19 deaths

Agren, David

The Lancet, Volume 396, Issue 10254, 807 


No patient safety without health worker safety

Shaw, Alexandra et al.

The Lancet, Volume 0, Issue 0 


Intranational differences in the case fatality rates for COVID-19 among Peruvian physicians. 

VALENZUELA-RODRIGUEZ G, Zambrano LI, Munoz-Lara F, Pecho-Silva S, et al.

Int J Infect Dis. 2020 Sep 13. pii: S1201-9712(20)30735. 


Occupational Safety and Health Administration (OSHA) and Worker Safety During the COVID-19 Pandemic.


JAMA. 2020 Sep 16. pii: 2770890. doi: 10.1001/jama.2020.16343.


Opioide und andere Substanzabhängigkeiten erhöhen Erkrankungsrisiko an COVID-19

Bethesda/Maryland – Patienten mit einer Abhängigkeit von Alkohol, Tabak, Cannabis, Opioiden oder Kokain haben ein deutlich erhöhtes Risiko, im Fall einer Infektion mit SARS-CoV-2 an COVID-19 zu erkranken. Dies geht aus einer Analyse von Patientenakten in Molecular Psychiatry (2020; DOI: 10.1038/s41380-020-00880-7) hervor. (aerzteblatt.de, 15.09.2020)


COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. 

Wang, Q.Q., Kaelber, D.C., Xu, R. et al. 

Mol Psychiatry (2020). doi.org/10.1038/s41380-020-00880-7


Max-Planck-Wissenschaftler sehen Zusammenhang zwischen Grippe- und Coronainfektion – Impfung empfohlen

Berlin/Paris – Die Abnahme der COVID-19-Fälle im Frühling hängt möglicherweise nicht nur mit den Gegenmaßnahmen, sondern auch mit dem Ende der Grippesaison zusammen.

Zu diesem Schluss kommen Forschende am Max-Planck-Institut für Infektionsbiologie (MPIIB) in Berlin und am Institut Pasteur in Paris auf der Basis eines mathematischen Modells die ersten Monate der Coronapandemie in Europa. Danach haben Grippeerkrankungen die Coronaübertragung im Durchschnitt um das 2,5-fache erhöht. (aerzteblatt.de, 15.09.2020)